Uncategorized
When a breast cancer diagnosis knocked me down, a network of Jewish women lifted me up
(JTA) — On the way home from the hospital where I was given my diagnosis of grade 2 invasive lobular breast cancer, I directed my husband, through my tears, to stop at the kosher store.
“I don’t want to see anyone right now,” I said, knowing the inevitability of running into someone we knew in the small Jewish community where we live, “so can you go in?” He pulled into the parking lot. “We need challah,” I reminded him. It was Thursday, after all. The next evening was Shabbat. Time doesn’t stand still for cancer.
My hospital appointment took place two days after the front page of the New York Times declared: “When Should Women Get Regular Mammograms: At 40, U.S. Panel Now Says.” I was 48. Breast cancer has long been the second most common cancer for women, after skin cancer. It is also the most lethal after lung cancer. Statistically, though, most women affected are postmenopausal, so unless there was a specific reason to test early, women were screened regularly from the age of 50. Now, the advice has changed. Breast cancer is rising in younger women. For women in their 40s, the rate of increase between 2015 and 2019 doubled from the previous decade to 2 per cent per year.
Why is this happening? Air pollution? Microplastics? Chemicals in our food? We don’t know.
In the days following my appointment, there was a proliferation of articles about the topic. Importantly, doctors explained that the cancer women are diagnosed with in their 40s tends to be a more aggressive type of cancer. Cancers in premenopausal women grow faster; many breast cancers, like mine, are hormone sensitive. (Got estrogen? Bad luck for you.)
When I posted the news about my diagnosis — on Facebook, because I’m an oversharing type — I was stunned by the number of friends my age, more discreet about their lives, who sent me messages to tell me they had recently gone through the same thing. Everyone had advice. “If you can do a lumpectomy, you’re very lucky. It’s not a major operation, and you’ll preserve your breast.” “Cut it all off! Immediately! Just get rid of all it and you’ll never worry again! Do you want to spend the rest of your life in mammogram scanxiety?” “Ask plastic surgeons for pictures, and pick the cutest new boobs out there. You won’t regret it.” “The radiation burns—that’s something no one ever tells you. Get yourself some Lubriderm and lidocaine, mix into a slurry, slap it on a panty liner, and tuck it in your sports bra.”
I’m not sure why I thought I was immune. Or maybe I didn’t — maybe I just never gave it much thought. Even when I found the lump on my breast, I was dismissive. I went to the doctor, and she asked if anyone in my family had had breast cancer. “Oh, who knows? They were all murdered,” I said blithely. Her eyes bugged. “In the Holocaust,” I added. “Your…mother? Grandmother? Sisters?” “Oh! No, no history of breast cancer in my immediate family.”
Add to that, my mother and sister both tested negative for the BRCA gene mutations, and that’s my Ashkenazi side. The thing is, though, most women who test positive for breast cancer have no family history of it.
But also, I’d done everything right! If you look through the preventative measures, I took all of them. I had three kids by 35, and I breastfed them. I have a healthy, mostly plant-based diet; I walk and cycle everywhere. I’m not a drinker or smoker. I eat so many blueberries!
Several of the articles that have been published in recent days are emphasizing the particular danger for Black women, with good reason: They have twice the mortality rate of white women. But as I did my research, I realized that Jewish women should also be on high alert. We’ve long known that one in forty Ashkenazi women has the BRCA gene mutation, significantly raising the risk of breast cancer (50% of women with the gene mutation will get breast cancer) as well ovarian cancer, which is much harder to detect and far more deadly. So many of my friends who reached out to me to tell me of their breast cancer experiences are Jewish; interestingly, not one has the BRCA mutation. Are these high numbers indicative or anecdotal? Are Jewish women generally more susceptible to breast cancer? This seems to be an important area of future research.
For me, that research will come too late — as did the guidance. For now, I have to accept that this cancer diagnosis is part of my life, that just as I will pick up challah every Thursday, I will wake every morning and take my hormone-blocking Tamoxifen. I will lose sleep every night about which surgery to have until I have the surgery, and then I will lose sleep every night about whether it was fully successful. And there’s plenty more in store for me that isn’t pretty; so it goes.
But here’s a good thing that’s already come out of this diagnosis: When the responses to my Facebook post flooded in, they were not only along the lines of “Refuah shleimah” and “I’ve just been through this too,” but also, “Thank you for sharing! I’m going to book my mammogram right now!”
—
The post When a breast cancer diagnosis knocked me down, a network of Jewish women lifted me up appeared first on Jewish Telegraphic Agency.
Uncategorized
Trump Official Resigns Over Iran War, Blames Israel
Mattie Neretin – CNP/Sipa USA via Reuters Connect
A senior U.S. counterterrorism official resigned Tuesday in protest of President Donald Trump’s military campaign against Iran, accusing Israel of playing an outsized role in pushing the United States into conflict.
Joe Kent, director of the National Counterterrorism Center, said he could not support the war, arguing Tehran posed “no imminent threat” to the United States. But it was Kent’s broader assertion, that pressure from Israel and pro-Israel voices influenced the decision to go to war, that drew swift pushback from the White House and national security experts.
In his resignation, Kent also drew parallels to the Iraq War, suggesting that similar dynamics shaped both conflicts, arguing that Israel pushed the US into the conflict. His comments revived long-running debates about how U.S. intelligence and foreign alliances factor into decisions to use military force, though many officials and analysts have rejected such comparisons as misleading.
“Iran posed no imminent threat to our nation, and it is clear that we started this war due to pressure from Israel and its powerful American lobby,” Kent wrote in his resignation letter.
Kent further claimed that he lost his wife in a “war manufactured by Israel.” Kent’s wife, Shannon Kent, died in 2019 when an ISIS suicide bomber detonated an explosive device during a U.S. military operation during the Syrian Civil War. Kent’s assertion suggests that Israel started the Syrian Civil War is completely unfounded. However, the notion that Israel controls the ISIS terror group is a popular conspiracy online.
The Trump administration forcefully disputed Kent’s claims, maintaining that the decision to strike Iran was based on credible intelligence about threats to U.S. forces and interests in the region. Trump dismissed Kent as “weak on security,” defending the operation as necessary to deter Iranian aggression and protect American personnel and allies.
Karoline Leavitt, White House Press Secretary, lambasted Kent’s letter as inaccurate .
“The absurd allegation that President Trump made this decision based on the influence of others, even foreign countries, is both insulting and laughable. President Trump has been remarkably consistent and has said for DECADES that Iran can NEVER possess a nuclear weapon,” she wrote.
National security experts and former officials also criticized Kent’s framing, arguing that it oversimplifies the policymaking process and risks promoting narratives that inaccurately portray Israel as driving U.S. military decisions. They emphasize that while Israel is a close ally that shares intelligence and strategic concerns, particularly regarding Iran’s nuclear ambitions and support for proxy groups, decisions to go to war are made by U.S. leadership based on American intelligence assessments.
Israel has long warned about the threat posed by Iran’s regional activities, including its backing of armed groups hostile to both Israeli and U.S. interests. Those concerns are broadly shared across multiple U.S. administrations and within the intelligence community, regardless of political party.
Kent’s resignation marks the most significant internal break so far over the Iran conflict and highlights growing divisions within the administration and across Washington. While some critics of the war have echoed his concerns about the lack of an imminent threat, others have expressed alarm at his decision to center Israel in his critique, warning that such claims can distort public understanding of how U.S. foreign policy decisions are made.
Kent came under fire during his confirmation process over his reported connections to white supremacists Nick Fuentes and Greyson Arnold. Kent admitted that he had conversations with Fuentes over social media strategy. However, Kent later distanced himself from Fuentes and repudiated his views.
Kent also holds other unorthodox foreign policy viewpoints, such as a relatively forgiving posture towards Russia’s invasion of Ukraine. In April 2022, following Moscow’s invasion of Ukraine, Kent argued that Putin was “very reasonable” and accused the US foreign policy establishment of aggravating Russia into war.
Kent’s comments on Tuesday drew widespread backlash from many who accused him of peddling antisemitic tropes. Ilan Goldberg, Senior Vice President and Chief Policy Officer of liberal pro-Israel organization J-Street, praised Kent for leaving the administration, but added “the antisemitic stuff in here blaming Israel for the Iraq war and a secret conspiracy of the media and Israelis to deceive Trump into going to war with Iran is ugly stuff that plays on the worst antisemitic tropes.”
“Donald Trump is the President of the United States and he is the one ultimately responsible for sending American troops into harms way,” Goldberg added.
Uncategorized
UK Hate Crime Prosecutions Reveal Stark Disparities Between Muslim and Jewish Victims
Demonstrators attend the “Lift The Ban” rally organised by Defend Our Juries, challenging the British government’s proscription of “Palestine Action” under anti-terrorism laws, in Parliament Square, in London, Britain, Sept. 6, 2025. Photo: REUTERS/Carlos Jasso
Hate crimes against Muslims in the United Kingdom are nearly twice as likely to result in prosecution as those targeting Jews, newly released figures show, exposing a striking imbalance in how justice is ultimately delivered.
According to data compiled by the British Home Office, the government department responsible for policing and security, figures on hate crime offences recorded over the past year show that Muslim victims of Islamophobic attacks were 76 percent more likely to see their attackers prosecuted than Jewish victims of antisemitic attacks.
Across the United Kingdom, 6.7 percent of hate crimes targeting Muslims led to a charge or summons — around one in 15 cases — compared with just 3.8 percent of offences against Jewish victims, or roughly one in 26, over the period from April 2024 to March 2025.
The gap is particularly stark in certain offences. Religiously aggravated assaults without injury against Muslims were over six times more likely to lead to prosecution, with 6.3 percent of cases resulting in charges compared with just 1.1 percent for Jewish victims.
Similarly, racially or religiously aggravated criminal damage was around four times more likely to result in charges, at 3.4 percent versus 0.8 percent.
Although 4,478 religious hate crimes were reported against Muslims compared with 2,873 against Jews, the smaller size of the Jewish population means such offences are far more concentrated and statistically significant. By raw population, the contrast is stark: around 3.9 million Muslims live in England and Wales, compared with 287,360 Jews
The Home Office’s data also reveals that Jewish people are disproportionately targeted, experiencing religious hate crimes at a rate roughly ten times higher than Muslims.
The Crown Prosecution Service (CPS) — the body responsible for bringing criminal cases in England and Wales — said comparing crime reports with prosecutions is difficult because cases can only proceed once police submit sufficient evidence for a charging decision.
According to the CPS, a record number of hate crime cases were referred by police last year, with 11,140 defendants prosecuted for racially flagged offences, resulting in a charge rate of 87.1 percent and a conviction rate of 85.2 percent.
In the UK, the Community Security Trust (CST) — a nonprofit charity that advises Britain’s Jewish community on security matters — recorded 1,521 antisemitic incidents from January to June last year. This was the second-highest number of antisemitic crimes ever recorded by CST in the first six months of any year, following 2,019 incidents in the first half of 2024.
Uncategorized
A government takeover could save a struggling Brooklyn hospital — while unsettling the Orthodox Jewish community it serves
As New York City moves to assume control of a financially distressed hospital that serves Brooklyn’s Orthodox Jewish community, some local players are pushing back, filing lawsuits in hopes of stopping the imminent merger with the city’s public hospital system.
Many Hasidic patients rely on Maimonides Medical Center, an independent nonprofit in Borough Park, as their local hospital. Even in a city where hospitals typically offer kosher food and are sensitive to Jewish patients’ needs, Maimonides stands out, with Shabbat elevators that stop on every floor, Yiddish-speaking staff and an onsite synagogue in the main lobby that hosts daily afternoon prayer.
New York City Health and Hospitals CEO Dr. Mitchell Katz has promised to retain those religious accommodations at Maimonides under the merger, noting in court documents that the merger agreement between Maimonides and the city requires preservation of existing religious and cultural practices at the hospital for at least 30 years.
“We certainly have heard concerns at community settings from the Orthodox Jewish community who are concerned about whether or not the hospital will still respect their cultural traditions,” Katz said at a New York City Council hearing earlier this month about the proposed merger. “And we’ve explained, ‘Absolutely.’” But, he acknowledged, “Change makes people worried.”
Such reassurances, however, have done little to assuage the plaintiffs in the pair of lawsuits seeking to block the merger, who include hospital’s trustees who disagreed with the decision to go public, Orthodox Jewish patient advocacy groups, and local Bobov, Satmar and Belz Hasidic congregations.
Their cases, filed against Maimonides Medical Center, the New York State Department of Health, and New York City Health and Hospitals, argue that relinquishing local control to the city hospital system jeopardizes the hospital’s Jewish character, conflicts with the nonprofit’s local mission, and threatens to deteriorate its quality of care.
The lawsuits have set up a clash between two groups who each argue they have the hospital’s best interest at heart: a city that says it wants to rescue a hospital on the brink of financial collapse, and Jewish leaders wary of public institutions, who prefer to keep the hospital’s management within the community it serves.
“Maybe at first you won’t see such a change in the culture, but over time, it’s inevitable that it’s just going to become a city-run hospital, like all the other city-run hospitals,” Martin Bienstock, a lawyer for the plaintiffs suing to block the merger, told the Forward. “If people lose trust in the hospital, because they lose that sense of affiliation, you’re going to get poorer health quality outcomes.”
The merger is set to be finalized on April 1, but could be disrupted by a judge’s pending decision on a request for a preliminary injunction blocking the transaction. The next hearing is scheduled for March 27.
A financial lifeline
Maimonides Medical Center, named for the 12th century Jewish scholar, was founded over a century ago by a group of Jewish women as a philanthropic effort to serve the poor. It has long served a diverse, largely low-income population that includes many immigrant communities, in addition to the Brooklyn neighborhood’s longstanding Jewish population.
Even as other independent hospitals shut down or merged with big medical systems, Maimonides held out. But recent years have brought mounting financial strain, exacerbated by the COVID-19 pandemic.
Last December, those financial troubles led the city to step in. Former Mayor Eric Adams, with just three days left in office, announced a plan to merge Maimonides Medical Center with the city’s public hospital system. Gov. Kathy Hochul endorsed the deal, backing it with a $2.2 billion grant as part of her broader push to stabilize New York’s struggling safety-net hospitals, which serve patients who can’t afford to pay for their care.
New York City’s public hospital system receives a higher Medicaid reimbursement rate than independent hospitals do — a potential lifeline for Maimonides, which receives 70% of its patient revenue from Medicare and Medicaid, according to the Healthcare Association of New York State.
The deal is poised to infuse Maimonides with more than $2 billion over five years, according to city hospital spokesperson Christopher Miller. The money will be used “for many important upgrades,” Miller said, including adopting electronic health records and renovating the hospital’s maternity ward, where more than 6,000 women give birth each per year — more babies than any other hospital in Brooklyn.
Advocates of the merger say that cash is urgently needed. Maimonides lost more than $165 million at its peak deficit in 2021 and has continued to operate tens of millions of dollars in the red in the years since, according to tax filings. A 2024 audit expressed “substantial doubt” about the organization’s ability to continue operating.
Those suing to block the transaction do not dispute that Maimonides’ finances are dire. But they argue that the hospital’s board did not adequately consider alternative options that could have allowed Maimonides to maintain its status as a private nonprofit, according to court documents that claim the hospital had snubbed potential partnerships with Touro University or Westchester Medical Center, according to court documents.
(The hospital’s CEO said in a court filing that he was not aware of any viable partners for Maimonides other than the city.)
Bienstock contends the merger will place Maimonides in the hands of an unwieldy government-sponsored bureaucracy — and under the political whims of New York City’s mayor, currently Zohran Mamdani, who oversees the city hospital system and proposes its budget.
“Any promises that they make, they’re always subject to later decisions by the Health and Hospitals board and mayor,” Bienstock said. “Ultimately, they’re going to be running the show.”
‘Grave concern’
It’s not the first time the hospital has had strained relations with the Orthodox community. During the pandemic, patients alleged that the hospital had removed patients from ventilators in ways that conflicted with Jewish values protecting the sanctity of life. Meanwhile, a campaign called “Save Maimonides,” led by local Orthodox Jewish leaders at odds with the leadership of CEO Ken Gibbs, alleged substandard patient care at the hospital and financial mismanagement.
Among the concerns was Maimonides Medical Center’s purchase of the naming rights to a minor league baseball stadium in Coney Island in 2021, and ballooning executive compensation even as the hospital lost millions. Gibbs’ salary was $3.2 million in 2020, up from $1.3 million the year prior, a payout hospital officials told THE CITY was deferred compensation Gibbs had been slated to receive after five years of work. Gibbs has earned roughly $1.8 million each year since.
In a statement to the Forward, Maimonides spokesperson Sam Miller said the hospital has won national recognition for “outstanding care across several clinical areas,” including top rank for its children’s hospital.
Asked about executive compensation and spending on the minor league baseball stadium, Miller said, “Our financial management is sound.”
Mendy Reiner, co-chair of “Save Maimonides” and founder of a nonprofit that connects patients with kidney donors, told the Forward he sees the proposed merger as yet another sign of the hospital’s decline. In his experience, locals who can afford to pay often travel across the river to Manhattan for what he described as superior care. U.S. News and World report currently ranks Maimonides 19th in the New York metro area, a market that includes some of the top-ranked academic hospitals in the nation.
“City hospitals are a failure across the board,” Reiner said. “And if we thought that Maimonides could go bad from bad to worse, here it is.”
In a statement, Miller said both Maimonides and NYC Health and Hospitals “run facilities that deliver high-quality care for their patients,” citing awards that include US News & World Report putting all 11 of the system’s hospitals on its “Best Hospitals 2025-2026” list.
H+H CEO Katz defended the public hospital system in court filings, arguing that the plaintiffs had made “inaccurate and baseless claims” about the quality of care and had “offensively” justified those allegations by pointing to the system’s large number of Medicaid patients.
Still, the proposed merger came as a shock to local state Assemblyman Simcha Eichenstein, who said he had been working with hospital leadership for years to come up with an alternative solution. In an October 2025 video address, he said the city’s proposal for Maimonides was “being shoved down our throats.”
“Let me be clear. This is a shortsighted, quick fix made without the slightest understanding of our local diverse neighborhoods,” Eichenstein said. “This is not collaboration. This is coercion.”
Hatzalah, the Jewish volunteer emergency medical service organization that partners with Maimonides, issued a letter last October “strongly” opposing the potential takeover as “not in the best interest of our community.” Hatzalah coordinators serving four heavily Orthodox Brooklyn neighborhoods — Borough Park, Crown Heights, Flatbush and Mill Basin — signed onto the letter “with grave concern.”
Since then, more Jewish institutions have joined the fight against the merger. Four Hasidic congregations — Congregation Khal Shaarei Zion Bobov, Congregation Kehilas Belz, Congregation Yetev Lev D’Satmar, and Khal Bobov 45 Inc. — signed onto the lawsuit filed against the hospital and state earlier this month, saying their congregants regularly rely on Maimonides for medical care. Other plaintiffs include Borough Park residents Chaim Beigel and Israel Minkoff, as well as the Orthodox Jewish patient advocacy groups Refuah Helpline and Chaim Medical Resource.
Miriam Knoll, CEO of the Jewish Orthodox Women’s Medical Association, said public hospitals can and do offer religious accommodations for Jewish patients. Still, she said, any new leadership must prioritize outreach to the local Jewish community to build trust.
For Knoll, the issue is close to home: She and all of her siblings were born at Maimonides, and her parents, both physicians, completed their medical residencies there.
“Maimonides is a deeply personal and important institution to the Jewish community in Brooklyn,” Knoll told the Forward. “And I think it’s very important that it continues to be a place that provides culturally sensitive care.”
The post A government takeover could save a struggling Brooklyn hospital — while unsettling the Orthodox Jewish community it serves appeared first on The Forward.
